Lamotrigine Level
This biomarker measures the concentration of lamotrigine, an anticonvulsant medication, in the blood to ensure therapeutic levels and avoid toxicity.
Lamotrigine levels are monitored to maintain therapeutic efficacy and prevent adverse effects.
Key facts at a glance
- Units
- mg/L
- Clinical utility
- monitoring
- Result kind
- quantitative
- FDA-cleared
- Roche Lamotrigine, Abbott Lamotrigine, MediBIR Lamotrigine
Lamotrigine is a medication primarily used in the treatment of epilepsy and bipolar disorder. Monitoring its blood levels helps ensure that the drug is within the therapeutic range, which is typically between 2–15 mg/L.
Levels below 2 mg/L may indicate insufficient drug concentration for seizure control or mood stabilization, while levels above 15 mg/L can lead to toxicity, manifesting as adverse effects such as dizziness, ataxia, or skin rashes.
Regular monitoring of lamotrigine levels is crucial, especially during dose adjustments or when patients experience unexpected side effects, to optimize treatment outcomes and patient safety.
Frequently asked questions
Why is it important to monitor lamotrigine levels?
What are the common side effects of high lamotrigine levels?
Sources
- 1Lamotrigine MonitoringSource
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy